Brokerages Set Johnson Matthey PLC (LON:JMAT) Price Target at GBX 1,985

Shares of Johnson Matthey PLC (LON:JMATGet Free Report) have earned an average rating of “Moderate Buy” from the six brokerages that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, one has given a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is GBX 1,985 ($25.09).

A number of research analysts have weighed in on the company. Jefferies Financial Group restated a “buy” rating and issued a GBX 2,100 ($26.54) price target on shares of Johnson Matthey in a research note on Wednesday, March 20th. Numis Securities reaffirmed a “buy” rating and issued a GBX 2,200 ($27.80) target price on shares of Johnson Matthey in a report on Wednesday, March 20th.

Check Out Our Latest Research Report on Johnson Matthey

Insider Buying and Selling

In other news, insider Stephen Oxley purchased 24 shares of the business’s stock in a transaction dated Wednesday, February 21st. The stock was bought at an average price of GBX 1,597 ($20.18) per share, with a total value of £383.28 ($484.37). Insiders bought 66 shares of company stock valued at $109,920 over the last quarter. 0.57% of the stock is owned by company insiders.

Johnson Matthey Trading Down 0.3 %

LON JMAT opened at GBX 1,789 ($22.61) on Monday. The company has a current ratio of 1.51, a quick ratio of 0.76 and a debt-to-equity ratio of 63.95. Johnson Matthey has a 12 month low of GBX 1,428.50 ($18.05) and a 12 month high of GBX 2,016.50 ($25.48). The company has a market capitalization of £3.28 billion, a PE ratio of 1,863.54, a P/E/G ratio of 49,242.50 and a beta of 0.96. The stock has a 50-day simple moving average of GBX 1,653.86 and a 200 day simple moving average of GBX 1,615.60.

About Johnson Matthey

(Get Free Report

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Recommended Stories

Analyst Recommendations for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.